Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT03902691 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Pegol-Sihematide
DRUG: ESPO

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.